Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/28438
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ng, Felix C | - |
dc.contributor.author | Churilov, Leonid | - |
dc.contributor.author | Yassi, Nawaf | - |
dc.contributor.author | Kleinig, Timothy J | - |
dc.contributor.author | Thijs, Vincent N | - |
dc.contributor.author | Wu, Teddy Y | - |
dc.contributor.author | Shah, Darshan G | - |
dc.contributor.author | Dewey, Helen M | - |
dc.contributor.author | Sharma, Gargan | - |
dc.contributor.author | Desmond, Patricia M | - |
dc.contributor.author | Yan, Bernard | - |
dc.contributor.author | Parsons, Mark W | - |
dc.contributor.author | Donnan, Geoffrey A | - |
dc.contributor.author | Davis, Stephen M | - |
dc.contributor.author | Mitchell, Peter J | - |
dc.contributor.author | Leigh, Richard | - |
dc.contributor.author | Campbell, Bruce C V | - |
dc.date | 2021-12-23 | - |
dc.date.accessioned | 2022-01-10T03:24:31Z | - |
dc.date.available | 2022-01-10T03:24:31Z | - |
dc.date.issued | 2022-05 | - |
dc.identifier.citation | Stroke 2022; 53(5): 1597-1605. | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/28438 | - |
dc.description.abstract | Factors contributing to cerebral edema in the post-hyperacute period of ischemic stroke (first 24-72 hours) are poorly understood. Blood-brain barrier (BBB) disruption and postischemic hyperperfusion reflect microvascular dysfunction and are associated with hemorrhagic transformation. We investigated the relationships between BBB integrity, cerebral blood flow, and space-occupying cerebral edema in patients who received acute reperfusion therapy. We performed a pooled analysis of patients treated for anterior circulation large vessel occlusion in the EXTEND-IA TNK and EXTEND-IA TNK part 2 trials who had MRI with dynamic susceptibility contrast-enhanced perfusion-weighted imaging 24 hours after treatment. We investigated the associations between BBB disruption and cerebral blood flow within the infarct with cerebral edema assessed using 2 metrics: first midline shift (MLS) trichotomized as an ordinal scale of negligible (<1 mm), mild (≥1 to <5 mm), or severe (≥5 mm), and second relative hemispheric volume (rHV), defined as the ratio of the 3-dimensional volume of the ischemic hemisphere relative to the contralateral hemisphere. Of 238 patients analyzed, 133 (55.9%) had negligible, 93 (39.1%) mild, and 12 (5.0%) severe MLS at 24 hours. The associated median rHV was 1.01 (IQR, 1.00-1.028), 1.03 (IQR, 1.01-1.077), and 1.15 (IQR, 1.08-1.22), respectively. MLS and rHV were associated with poor functional outcome at 90 days (P<0.002). Increased BBB permeability was independently associated with more edema after adjusting for age, occlusion location, reperfusion, parenchymal hematoma, and thrombolytic agent used (MLS cOR, 1.12 [95% CI, 1.03-1.20], P=0.005; rHV β, 0.39 [95% CI, 0.24-0.55], P<0.0001), as was reduced cerebral blood flow (MLS cOR, 0.25 [95% CI, 0.10-0.58], P=0.001; rHV β, -2.95 [95% CI, -4.61 to -11.29], P=0.0006). In subgroup analysis of patients with successful reperfusion (extended Treatment in Cerebral Ischemia 2b-3, n=200), reduced cerebral blood flow remained significantly associated with edema (MLS cOR, 0.37 [95% CI, 0.14-0.98], P=0.045; rHV β, -2.59 [95% CI, -4.32 to -0.86], P=0.004). BBB disruption and persistent hypoperfusion in the infarct after reperfusion treatment is associated with space-occupying cerebral edema. Further studies evaluating microvascular dysfunction during the post-hyperacute period as biomarkers of poststroke edema and potential therapeutic targets are warranted. | en |
dc.language.iso | eng | - |
dc.subject | blood-brain barrier | en |
dc.subject | hematoma | en |
dc.subject | magnetic resonance imaging | en |
dc.subject | perfusion | en |
dc.subject | permeability | en |
dc.title | Microvascular Dysfunction in Blood-Brain Barrier Disruption and Hypoperfusion Within the Infarct Posttreatment Are Associated With Cerebral Edema. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Stroke | en |
dc.identifier.affiliation | Neurology.. | en |
dc.identifier.affiliation | The Florey Institute of Neuroscience and Mental Health.. | en |
dc.identifier.affiliation | Medicine (University of Melbourne).. | en |
dc.identifier.affiliation | Department of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.. | en |
dc.identifier.affiliation | Department of Radiology, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.. | en |
dc.identifier.affiliation | Department of Neurology, Royal Adelaide Hospital, Australia.. | en |
dc.identifier.affiliation | Department of Neurology, Christchurch Hospital, New Zealand.. | en |
dc.identifier.affiliation | Department of Neurology, Princess Alexandra Hospital, Brisbane, Australia.. | en |
dc.identifier.affiliation | Eastern Health and Eastern Health Clinical School, Department of Neurosciences, Monash University, Clayton, Australia.. | en |
dc.identifier.affiliation | Department of Neurology, John Hopkins University, Baltimore, MD.. | en |
dc.identifier.affiliation | Population Health and Immunity Division. The Walter and Eliza Hall Institute of Medical Research. Parkville, Australia.. | en |
dc.identifier.pubmeduri | https://pubmed.ncbi.nlm.nih.gov/34937423/ | en |
dc.identifier.doi | 10.1161/STROKEAHA.121.036104 | en |
dc.type.content | Text | en |
dc.identifier.orcid | 0000-0001-6973-8677 | en |
dc.identifier.orcid | 0000-0002-9807-6606 | en |
dc.identifier.orcid | 0000-0002-0685-0060 | en |
dc.identifier.orcid | 0000-0003-4430-3276 | en |
dc.identifier.orcid | 0000-0002-6614-8417 | en |
dc.identifier.orcid | 0000-0003-1845-1769 | en |
dc.identifier.orcid | 0000-0002-5254-219X | en |
dc.identifier.orcid | 0000-0001-9484-2070 | en |
dc.identifier.orcid | 0000-0002-4803-6323 | en |
dc.identifier.orcid | 0000-0001-8802-9606 | en |
dc.identifier.orcid | 0000-0001-8874-2487 | en |
dc.identifier.orcid | 0000-0001-6324-3403 | en |
dc.identifier.orcid | 0000-0003-0962-2300 | en |
dc.identifier.orcid | 0000-0002-8337-7529 | en |
dc.identifier.orcid | 0000-0002-8285-1815 | en |
dc.identifier.orcid | 0000-0003-3632-9433 | en |
dc.identifier.pubmedid | 34937423 | - |
local.name.researcher | Churilov, Leonid | |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Neurology | - |
crisitem.author.dept | Medicine (University of Melbourne) | - |
crisitem.author.dept | The Florey Institute of Neuroscience and Mental Health | - |
crisitem.author.dept | Neurology | - |
crisitem.author.dept | The Florey Institute of Neuroscience and Mental Health | - |
crisitem.author.dept | The Florey Institute of Neuroscience and Mental Health | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.